CollPlant Biotechnologies... (CLGN)
| Bid | 2.06 |
| Market Cap | 35.51M |
| Revenue (ttm) | 650K |
| Net Income (ttm) | -17.42M |
| EPS (ttm) | -1.53 |
| PE Ratio (ttm) | -2.03 |
| Forward PE | -9.62 |
| Analyst | Buy |
| Ask | 3.4 |
| Volume | 69,220 |
| Avg. Volume (20D) | 7,506 |
| Open | 3.16 |
| Previous Close | 3.10 |
| Day's Range | 3.04 - 3.65 |
| 52-Week Range | 3.00 - 6.75 |
| Beta | 0.70 |
About CLGN
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and...
Analyst Forecast
According to 3 analyst ratings, the average rating for CLGN stock is "Buy." The 12-month stock price forecast is $14, which is an increase of 351.61% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago · seekingalpha.com
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call TranscriptCollPlant Biotechnologies Ltd (NASDAQ:CLGN ) Q3 2024 Earnings Conference Call November 27, 2024 10:00 AM ET Company Participants Dory Kurowski - LifeSci Advisors Yehiel Tal - CEO Eran Rotem - Deputy C...